X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (778) 778
Book Chapter (232) 232
Patent (19) 19
Publication (6) 6
Magazine Article (3) 3
Conference Proceeding (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (437) 437
life sciences & biomedicine (419) 419
humans (406) 406
male (285) 285
female (238) 238
umcg approved (227) 227
middle aged (199) 199
aged (162) 162
urology & nephrology (157) 157
risk factors (138) 138
adult (119) 119
albuminuria (116) 116
animals (105) 105
proteinuria (92) 92
cardiovascular system & cardiology (90) 90
nephropathy (87) 87
hypertension (85) 85
glomerular filtration rate (84) 84
diabetes (82) 82
nephrology (82) 82
blood pressure (79) 79
mortality (72) 72
type 2 diabetes (71) 71
diabetes mellitus, type 2 - complications (67) 67
angiotensin-converting enzyme inhibitors - therapeutic use (66) 66
blood pressure - drug effects (65) 65
kidney diseases (65) 65
microalbuminuria (65) 65
rats (65) 65
abridged index medicus (62) 62
peripheral vascular disease (61) 61
chronic kidney-disease (58) 58
double-blind method (58) 58
disease (56) 56
progression (55) 55
cardiovascular disease (54) 54
disease progression (54) 54
glomerular-filtration-rate (54) 54
risk (54) 54
diabetes mellitus (53) 53
diabetes mellitus, type 2 - drug therapy (53) 53
treatment outcome (53) 53
antihypertensive agents - therapeutic use (52) 52
blood-pressure (49) 49
cardiovascular diseases (49) 49
diabetic nephropathies - drug therapy (49) 49
pharmacology & pharmacy (49) 49
cardiac & cardiovascular systems (48) 48
chronic kidney disease (45) 45
kidney - drug effects (45) 45
proteinuria - drug therapy (45) 45
endocrinology & metabolism (42) 42
rats, wistar (42) 42
hypertension - drug therapy (41) 41
general & internal medicine (40) 40
kidney - physiopathology (39) 39
medicine, general & internal (39) 39
cohort studies (37) 37
prognosis (37) 37
time factors (37) 37
drug therapy (36) 36
losartan (36) 36
albuminuria - drug therapy (35) 35
diabetic nephropathy (35) 35
follow-up studies (35) 35
outcomes (35) 35
renin-angiotensin system - drug effects (35) 35
research (35) 35
kidney (34) 34
predictive value of tests (34) 34
creatinine - blood (33) 33
prospective studies (33) 33
analysis (32) 32
cardiovascular diseases - prevention & control (32) 32
dose-response relationship, drug (32) 32
transplantation (32) 32
urologic and male genital diseases (31) 31
albuminuria - epidemiology (30) 30
clinical trials (30) 30
urinary albumin excretion (30) 30
cardiovascular diseases - etiology (29) 29
cardiovascular diseases - mortality (29) 29
glomerular filtration rate - drug effects (29) 29
health aspects (29) 29
kidney failure, chronic - prevention & control (29) 29
angiotensin (28) 28
creatinine (28) 28
heart failure (28) 28
angiotensin-converting enzyme inhibitors - pharmacology (27) 27
canagliflozin (27) 27
drug therapy, combination (27) 27
hypertension - physiopathology (27) 27
mellitus (27) 27
albuminuria - physiopathology (26) 26
population (26) 26
prevention (26) 26
albuminuria - complications (24) 24
albuminuria - diagnosis (24) 24
care and treatment (24) 24
complications and side effects (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1018) 1018
Dutch (20) 20
French (9) 9
German (5) 5
Spanish (3) 3
Japanese (2) 2
Portuguese (2) 2
Chinese (1) 1
Danish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 08/2017, Volume 377, Issue 7, pp. 644 - 657
In this report of two randomized trials, patients with type 2 diabetes at risk for cardiovascular disease received the sodium–glucose cotransporter 2 inhibitor... 
METAANALYSIS | ATRIAL-NATRIURETIC-PEPTIDE | RATIONALE | INTENSIVE GLUCOSE CONTROL | PLACEBO-CONTROLLED TRIAL | OUTCOMES | INHIBITORS | STAGE KIDNEY-DISEASE | PROGRESSION | BASE-LINE CHARACTERISTICS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Albuminuria - complications | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Kidney Diseases - mortality | Male | Canagliflozin - adverse effects | Disease Progression | Foot - surgery | Glomerular Filtration Rate - drug effects | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin - therapeutic use | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Aged | Amputation - statistics & numerical data | Kidney Diseases - etiology | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Type 2 diabetes | Heart | Complications and side effects | Care and treatment | Abnormalities | Amputation | Myocardial infarction | Heart attacks | Body weight | Clinical trials | Cardiovascular disease | Blood pressure | Drug dosages | Heart failure | Cerebral infarction | Stroke | Statistical analysis | Kidneys | Metatarsal | Diabetes mellitus | Toe | FDA approval | Glomerular filtration rate | Medicine | Studies | Side effects | Sodium | Diabetes | Kidney diseases | Cardiovascular diseases | Health risk assessment | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2181 - 2192
Summary Background Lowering LDL cholesterol with statin regimens reduces the risk of myocardial infarction, ischaemic stroke, and the need for coronary... 
Internal Medicine | UNITED-KINGDOM HEART | DESIGN | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | HEMODIALYSIS | OUTCOMES | UMCG Approved | PARTICIPANTS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Confidence Intervals | Simvastatin - adverse effects | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Renal Dialysis - methods | Male | Reference Values | Cholesterol, LDL - analysis | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Azetidines - administration & dosage | Hypolipidemic Agents - administration & dosage | Survival Analysis | Aged | Simvastatin | Low density lipoproteins | Physiological aspects | Drug therapy, Combination | Research | Kidney diseases | Diagnosis | Drug therapy | Health aspects | Studies | Heart failure | Cardiac arrhythmia | Medical imaging | Hospitals | Compliance | Cardiovascular disease | Blood pressure | Family medical history | Cholesterol | Cancer | Index Medicus | Abridged Index Medicus | Mortality | myocardial infarction | cholesterol | councils | Dialysis | medical research | stroke | Kidney | Fast track
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2009, Volume 373, Issue 9668, pp. 1009 - 1015
Journal Article
The New England journal of medicine, ISSN 1533-4406, 09/2001, Volume 345, Issue 12, pp. 861 - 869
Journal Article